S. Korea to Mass-Produce Antibody Treatment of COVID-19 This Month
Saudi Press Agency
Tuesday 1442/1/20 - 2020/09/08
Seoul, Sep 8, 2020, SPA -- South Korea plans to mass-produce an antibody treatment of the novel coronavirus later this month, Yonhap quoted health authorities as saying today, on Tuesday.
The country's drug ministry is currently reviewing phase 2/3 clinical tests for the antibody-based treatment and aims to mass-produce commercial antibodies for the novel coronavirus in September, according to Kwon Jun-wook, deputy chief at the Central Disease Control Headquarters.
Health researchers are currently analyzing results phase 1 trial, which was approved by the drug ministry on July 17. They also earned approval for phase 1 study of the treatment in Britain on July 29.
For blood plasma-based treatment, health authorities said the drug ministry approved phase 2 study of its development on Aug. 20, and six medical institutions, including Samsung Medical Center and Asan Medical Center, will verify its effectiveness and safety on COVID-19 patients.
Health authorities added the blood plasma material for phase 2 trial will begin production Tuesday and supply of the substance will be completed in mid-October.
19:40 LOCAL TIME 16:40 GMT
|Join the GlobalSecurity.org mailing list|